Citations 1
Blinded Independent Central Review of the Progression-Free Survival Endpoint
Amit, Ohad, Bushnell, Will, Dodd, Lori E. , Roach, Nancy, Sargent, Daniel J. , Bushnell, William D., Sargent, Daniel J
The Oncologist | May 20, 2010 | Volume: 15 | Issue: 5 | Pages: 492-495
10.1634/theoncologist.2009-0261
Presented are the efforts of the Pharmaceutical Research and Manufacturing Association PFS Working Group to address concerns related to blinded independent central review of locally evaluated progression times and the proposed audit methodology to minimize potential biases, along with the U.S. Food and Drug Administration's comments on this work.